DUEARITY AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.38 SEK | -0.13% |
|
-2.44% | -82.88% |
| Mar. 11 | Duearity Unit Signs US Distribution Deal With Westone Laboratories | MT |
| Mar. 10 | Duearity Americas Inc Enters into an Agreement with Westone Laboratories | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Duearity AB is a Sweden-based medical technology company. The Company's product is Tinearity G1. Tinearity G1 is a medical device that helps with tinnitus treatment. Tinearity G1 is based on Tinnitus Retraining Therapy, a white noise treatment that has been used clinically for several decades. Tinearity G1 consists of sound elements that lead white noise to the inner ear via the skull bone. The method is non-invasive and the ear canal is not affected.
Calendar
2024-05-15
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -82.88% | 937K | |
| +9.80% | 34.16B | |
| +24.92% | 8.13B | |
| +36.69% | 4.44B | |
| -28.70% | 2.7B | |
| -20.62% | 1.37B | |
| -28.50% | 1.27B | |
| -32.48% | 1.18B | |
| +12.29% | 1B | |
| -37.86% | 870M |
- Stock Market
- Equities
- DEAR Stock
- News Duearity AB
- Sweden's Duearity Lands Deals for Tinnitus Device in US